X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125290
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471
https://www.clinicaltrialsarena.com/news/novartis-ofatumumab-phase-iii/
https://www.marketwatch.com/press-release/biocurepharm-korea-bpk-announces-closing-of-private-placement-2019-02-28
https://www.newsfilecorp.com/release/42901/Biocure-Technology-Corp-Announces-a-MOU-with-the-Government-of-Uzbekistan-and-GoldDream-LLC-to-Build-a-Manufacturing-Plant-to-Produce-Biosimilars
https://www.prnewswire.com/news-releases/bayer-updates-betaseron-interferon-beta-1b-prescribing-information-in-accordance-with-the-us-food-and-drug-administrations-pregnancy-and-lactation-labeling-rule-300764975.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125290
https://www.biocentury.com/bc-extra/preclinical-news/2018-11-07/gsk%E2%80%99s-systemic-sting-agonist-could-overcome-delivery-hurdles
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103471
http://www.pharmatimes.com/news/price_cuts_secure_nhs_place_for_ms_drugs_1235371
https://www.prnewswire.com/news-releases/emd-serono-highlights-commitment-to-advance-multiple-sclerosis-treatment-with-investigational-cladribine-tablets-and-rebif-data-at-aan-2018-300629564.html
https://www.biospace.com/article/novartis-published-multiple-sclerosis-trial-data-with-plans-to-file-for-fda-approval/
Market Place
Share 
